**Core Concept:** Long-acting insulins are designed to provide basal insulin secretion for a prolonged period, while rapid-acting insulins mimic the early postprandial insulin response. Mixing them can be beneficial for better glycemic control and convenience in insulin therapy.

**Why the Correct Answer is Right:** Insulin glargine (D) is a long-acting basal insulin analogue that has a flat glucose-lowering effect over 24 hours, with a peak effect occurring around 24 hours after injection. Mixing insulin glargine with rapid-acting insulin allows for a combination that can mimic the natural insulin response to food intake, providing better glycemic control.

**Why Each Wrong Option is Incorrect:**

A. Insulin detemir (C) is also a long-acting insulin analogue, but its peak action occurs 2-6 hours after injection. Mixing it with rapid-acting insulin would lead to an inconsistent glucose-lowering effect and is generally not recommended.

B. Insulin aspart (A) and insulin lispro (B) are rapid-acting insulin analogues, which are designed to mimic the early postprandial insulin response. Mixing them with long-acting insulin creates an inconsistent glucose-lowering effect and is not recommended for clinical practice.

**Clinical Pearl:** Mixing long-acting and rapid-acting insulin analogues can lead to inconsistent glucose-lowering effects and is not recommended in clinical practice. Instead, consider using premixed insulin preparations (e.g., 70:30, 50:50, or 30:70) for improved insulin therapy.

**Correct Answer:** D. Insulin glargine is the correct option because it has a long half-life, allowing for a flat glucose-lowering effect over 24 hours, with a peak effect around 24 hours after injection. Mixing insulin glargine with rapid-acting insulin creates a combination that can better mimic the natural insulin response to food intake and improve glycemic control.